Mechanistic models of cancer Mechanistic models cancer-immune cycle and immunotherapies Poster Mechanistic models of cancer Mechanistic models cancer-immune cycle and immunotherapies CertaraJune 24, 2019
Integration of a Tumour Growth Inhibition Model within a Mouse Physiologically-Based Pharmacokinetic Model Poster Integration of a Tumour Growth Inhibition Model within a Mouse Physiologically-Based Pharmacokinetic Model CertaraJune 24, 2019
Optimize Immuno-oncology Drug Discovery and Development Using QSP White Paper Optimize Immuno-oncology Drug Discovery and Development Using QSP A Quantitative Systems Pharmacology (QSP) approach for developing combination immune-oncology therapies can be used to…CertaraJune 19, 2019
Pirana Modeling Workbench Brochure Pirana Modeling Workbench Pirana is a flexible and extendible modeling workbench with an intuitive graphical user interface for…CertaraMay 28, 2019
Evidence and Access Overview Brochure Evidence and Access Overview Discover Certara’s holistic approach to market access.CertaraMay 21, 2019
Advanced Analytics Using RWD Mitigates Risks in AD Drug Development & Reimbursement On-Demand Webinar Advanced Analytics Using RWD Mitigates Risks in AD Drug Development & Reimbursement This webinar explained how advanced analytics using real-world data can mitigate challenges in Alzheimer’s disease…CertaraMay 13, 2019
Trends for Market Access, HEOR, and Real World Evidence Blog Trends for Market Access, HEOR, and Real World Evidence This blog reviews trends for using health economics and outcomes research and real-world evidence to…CertaraMay 10, 2019
Population Pharmacokinetic Analysis of DS-8201a, A HER2-Targeting Antibody-Drug Conjugate, in Patients with HER2-Positive Breast Cancer or Other Solid Tumors Poster Population Pharmacokinetic Analysis of DS-8201a, A HER2-Targeting Antibody-Drug Conjugate, in Patients with HER2-Positive Breast Cancer or Other Solid Tumors CertaraMay 2, 2019
Simulating the Impact of the Interplay Between CYP2C19 Polymorphisms and Ethnicity on Response to Clopidogrel, Using PBPK-PD Models Poster Simulating the Impact of the Interplay Between CYP2C19 Polymorphisms and Ethnicity on Response to Clopidogrel, Using PBPK-PD Models CertaraApril 22, 2019
Development of a Physiologically-Based Pharmacokinetic Model for Topical Lidocaine in Order to Predict Systemic Absorption in Healthy Volunteers, Geriatrics, and Pediatrics Poster Development of a Physiologically-Based Pharmacokinetic Model for Topical Lidocaine in Order to Predict Systemic Absorption in Healthy Volunteers, Geriatrics, and Pediatrics CertaraApril 22, 2019